APERIO® Hybrid Thrombectomy Device

Highly visible Nitinol stent retriever for fast flow restoration

APERIO® Hybrid 17 Thrombectomy Device

  • Excellent full length visibility
  • Hybrid cell design for successfull recanalisation*
  • Excellent visibility
  • CE mark approved for vessel diameters from 1.5 – 5.5 mm
  • Compatible with 0.021’’ – 0.027’’ ID microcatheters

* Kaschner, M. et al. (2020): The new fully radiopaque Aperio Hybrid stent retriever: Efficient and safe? An early Multicenter Experience. World Neurosurgery, 2020, 141 (September), pp. e278-e288

 
 
 

Clearly Visible

aperio hybrid clear visible

 
 

Clinical Results

97.9 %

95.8 %

60.4 %

Very good device visibility

mTICI 2b-3 Overall

First pass effect

Kaschner, M. et al. (2020): The new fully radiopaque Aperio Hybrid stent retriever: Efficient and safe? An early Multicenter Experience. World Neurosurgery, 2020, 141 (September), pp. e278-e288

Find clinical studies and publications on our products. Learn more >

 
 

Clinical Experience with APERIO® Hybrid Thrombectomy Device

Pre treatment Total occlusion of basilar artery

Pre treatment
Total occlusion of basilar artery

Treatment with APERIO® Hybrid Thrombectomy Device 4.5 x 50 mm

Treatment
with APERIO® Hybrid Thrombectomy Device

Post treatment Final result: TICI III (first pass)

Post treatment
Final result: TICI III (first pass)

 

Images are courtesy of Dr. Christoph Kabbasch, University Hospital Cologne, Germany

 
 

Disclaimer:
Please consult the Instructions for Use for all indications, contraindications, warnings, cautions as well as possible adverse effects. Acandis® products are to be used exclusively by trained medical professionals. Orders are taken only in regions where the product is approved. Please contact an Acandis® representative for product availability.